C76.52 — Malignant neoplasm of left lower limb
Is C76.52 billable?
Yes — C76.52 is billable for FY2027. C76.52 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C76.52 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C76.52 at a glance
| Code | C76.52 |
|---|---|
| Description | Malignant neoplasm of left lower limb |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C76.52 group to?
C76.52 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCsurgical
- 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCsurgical
- 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCsurgical
Excludes1 — never code together — inherited from C76
The conditions below can never be reported together with C76.52 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
How long has C76.52 existed?
C76.52 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.